Derek Meisner
Vermögen: 374 098 $ am 31.07.2026
Vermögen: 374 098 $ am 31.07.2026
Derek M.
Meisner is Secretary & Chief Legal Officer at Acumen Pharmaceuticals, Inc. since 2022.
Mr. Meisner is Vice President-Operations at Greenfire Resources Ltd. starting in 2026.
Former positions include General Counsel at RA Capital Management LP, Partner at K&L Gates LLP, General Counsel at Quantopian, Inc. from 2016 to 2018, Principal at the US Securities & Exchange Commission, General Counsel at Genocea Biosciences, Inc. from 2018 to 2019, and Secretary & Chief Legal Officer at X4 Pharmaceuticals, Inc. from 2019 to 2022.
Education includes undergraduate studies at the University of Michigan and graduate studies at American University Washington College of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.03.2026 | 173’999 ( 0.24% ) | 374 098 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | General Counsel | 01.08.2022 |
| GREENFIRE RESOURCES LTD. | Geschäftsführer | 12.03.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | General Counsel | 22.08.2022 |
| GENOCEA BIOSCIENCES, INC. | General Counsel | 01.11.2019 |
Quantopian, Inc.
Quantopian, Inc. Internet Software/ServicesTechnology Services Operates as an online crowdsourced algorithmic trading platform that enables users to develop, test and license trading strategies | General Counsel | 01.01.2018 |
US Securities & Exchange Commission
US Securities & Exchange Commission Investment Banks/BrokersFinance Provides securities and commission services | Corporate Officer/Principal | - |
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Finance |
Genocea Biosciences, Inc.
Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Securities & Exchange Commission
US Securities & Exchange Commission Investment Banks/BrokersFinance Provides securities and commission services | Finance |
K&L Gates LLP
K&L Gates LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Quantopian, Inc.
Quantopian, Inc. Internet Software/ServicesTechnology Services Operates as an online crowdsourced algorithmic trading platform that enables users to develop, test and license trading strategies | Technology Services |
American University Washington College of Law
American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Greenfire Resources Ltd.
Greenfire Resources Ltd. Integrated OilEnergy Minerals Explores, acquires, develops and produces oil and gas | Energy Minerals |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen